Sysmex Corporation

TSE:6869 Stock Report

Market Cap: JP¥1.8t

Sysmex Valuation

Is 6869 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6869 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6869 (¥2882) is trading below our estimate of fair value (¥3099.19)

Significantly Below Fair Value: 6869 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6869?

Other financial metrics that can be useful for relative valuation.

6869 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.6x
Enterprise Value/EBITDA14.4x
PEG Ratio2.8x

Price to Earnings Ratio vs Peers

How does 6869's PE Ratio compare to its peers?

The above table shows the PE ratio for 6869 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average47.3x
7733 Olympus
115.6x24.1%JP¥3.2t
4543 Terumo
37.1x11.4%JP¥4.4t
6849 Nihon Kohden
26.5x13.1%JP¥371.1b
7716 Nakanishi
10.1x-5.8%JP¥219.4b
6869 Sysmex
34.5x12.5%JP¥1.8t

Price-To-Earnings vs Peers: 6869 is good value based on its Price-To-Earnings Ratio (34.5x) compared to the peer average (47.5x).

Price to Earnings Ratio vs Industry

How does 6869's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a13.8%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a13.8%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: 6869 is expensive based on its Price-To-Earnings Ratio (34.5x) compared to the JP Medical Equipment industry average (17.6x).

Price to Earnings Ratio vs Fair Ratio

What is 6869's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6869 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio34.5x
Fair PE Ratio28.1x

Price-To-Earnings vs Fair Ratio: 6869 is expensive based on its Price-To-Earnings Ratio (34.5x) compared to the estimated Fair Price-To-Earnings Ratio (28.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6869 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,882.00
JP¥3,097.33
+7.5%
12.8%JP¥3,800.00JP¥2,500.00n/a15
Oct ’25JP¥2,875.50
JP¥3,057.33
+6.3%
11.7%JP¥3,600.00JP¥2,500.00n/a15
Sep ’25JP¥2,820.00
JP¥3,080.71
+9.2%
11.2%JP¥3,600.00JP¥2,500.00n/a14
Aug ’25JP¥2,492.00
JP¥3,126.79
+25.5%
12.4%JP¥3,655.00JP¥2,500.00n/a14
Jul ’25JP¥2,526.50
JP¥3,136.07
+24.1%
12.8%JP¥3,655.00JP¥2,500.00n/a14
Jun ’25JP¥2,679.50
JP¥3,057.08
+14.1%
12.7%JP¥3,655.00JP¥2,500.00n/a12
May ’25JP¥2,641.50
JP¥3,050.41
+15.5%
12.0%JP¥3,655.00JP¥2,500.00n/a13
Apr ’25JP¥2,688.50
JP¥3,049.16
+13.4%
12.0%JP¥3,655.00JP¥2,466.66n/a13
Mar ’25JP¥2,802.67
JP¥3,051.67
+8.9%
12.0%JP¥3,655.00JP¥2,466.67n/a13
Feb ’25JP¥2,636.33
JP¥2,993.97
+13.6%
12.2%JP¥3,655.00JP¥2,500.00n/a13
Jan ’25JP¥2,619.33
JP¥2,978.59
+13.7%
12.2%JP¥3,655.00JP¥2,500.00n/a13
Dec ’24JP¥2,692.67
JP¥2,970.60
+10.3%
11.8%JP¥3,655.00JP¥2,500.00n/a14
Nov ’24JP¥2,436.00
JP¥2,946.79
+21.0%
11.8%JP¥3,655.00JP¥2,500.00n/a13
Oct ’24JP¥2,377.67
JP¥3,006.82
+26.5%
11.8%JP¥3,655.00JP¥2,600.00JP¥2,875.5011
Sep ’24JP¥2,621.33
JP¥3,039.67
+16.0%
12.6%JP¥4,000.00JP¥2,666.67JP¥2,820.0010
Aug ’24JP¥3,182.00
JP¥3,311.52
+4.1%
10.8%JP¥4,000.00JP¥2,766.67JP¥2,492.0011
Jul ’24JP¥3,267.33
JP¥3,306.06
+1.2%
15.0%JP¥4,233.33JP¥2,733.33JP¥2,526.5011
Jun ’24JP¥3,104.67
JP¥3,216.67
+3.6%
14.1%JP¥4,000.00JP¥2,633.33JP¥2,679.5012
May ’24JP¥3,000.00
JP¥3,076.39
+2.5%
12.6%JP¥3,900.00JP¥2,633.33JP¥2,641.5012
Apr ’24JP¥2,881.00
JP¥3,072.22
+6.6%
13.3%JP¥3,900.00JP¥2,633.33JP¥2,688.5012
Mar ’24JP¥2,683.33
JP¥3,133.33
+16.8%
13.7%JP¥3,900.00JP¥2,633.33JP¥2,802.6713
Feb ’24JP¥2,853.33
JP¥3,133.33
+9.8%
13.9%JP¥3,900.00JP¥2,633.33JP¥2,636.3313
Jan ’24JP¥2,666.00
JP¥3,179.49
+19.3%
14.8%JP¥4,000.00JP¥2,433.33JP¥2,619.3313
Dec ’23JP¥2,836.33
JP¥3,187.18
+12.4%
14.8%JP¥4,000.00JP¥2,433.33JP¥2,692.6713
Nov ’23JP¥2,657.00
JP¥3,224.36
+21.4%
18.4%JP¥4,666.67JP¥2,433.33JP¥2,436.0013
Oct ’23JP¥2,589.33
JP¥3,260.26
+25.9%
18.5%JP¥4,500.00JP¥2,433.33JP¥2,377.6713

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y